Search hospitals > California > Long Beach
Veterans Affairs Medical Center - Long Beach
Claim this profileLong Beach, California 90822
Global Leader in Prostate Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Hepatitis
Conducts research for Hepatitis C
273 reported clinical trials
19 medical researchers
Summary
Veterans Affairs Medical Center - Long Beach is a medical facility located in Long Beach, California. This center is recognized for care of Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Hepatitis, Hepatitis C and other specialties. Veterans Affairs Medical Center - Long Beach is involved with conducting 273 clinical trials across 356 conditions. There are 19 research doctors associated with this hospital, such as Pankaj Gupta, Michael Hollifield, MD, Helen Ma, MD, and Kamyar Kalantar-Zadeh, MD PhD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
TP53 positive
TP53 negative
2Lung Cancer
Global LeaderStage I
Stage II
Stage III
Top PIs
Pankaj GuptaTibor Rubin VA Medical Center6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
30 drugs studied
Michael Hollifield, MDVA Long Beach Healthcare System, Long Beach, CA5 years of reported clinical research
Studies Post-Traumatic Stress Disorder
Studies PTSD
4 reported clinical trials
5 drugs studied
Helen Ma, MDTibor Rubin VA Medical Center4 years of reported clinical research
Studies Lymphoma
Studies Peripheral T-Cell Lymphoma
4 reported clinical trials
19 drugs studied
Kamyar Kalantar-Zadeh, MD PhDVA Long Beach Healthcare System, Long Beach, CA2 years of reported clinical research
Studies Dialysis
Studies Contrast-induced Nephropathy
1 reported clinical trial
2 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Long Beach
Prostate Cancer
Lung Cancer
Post-Traumatic Stress Disorder
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Insomnia
Thyroid Cancer
Lymphoma
Parkinson's Disease
Atherosclerosis
Carboplatin + Cabazitaxel
for Prostate Cancer
This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that has spread from where it first started (primary site) to other places in the body (metastatic). Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Chemotherapy drugs, such as cabazitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Prednisone is often given together with chemotherapy drugs. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs and to help the chemotherapy work. Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.
Recruiting2 awards Phase 35 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Long Beach?
Veterans Affairs Medical Center - Long Beach is a medical facility located in Long Beach, California. This center is recognized for care of Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Hepatitis, Hepatitis C and other specialties. Veterans Affairs Medical Center - Long Beach is involved with conducting 273 clinical trials across 356 conditions. There are 19 research doctors associated with this hospital, such as Pankaj Gupta, Michael Hollifield, MD, Helen Ma, MD, and Kamyar Kalantar-Zadeh, MD PhD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.